Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

More Data Support Trodelvy-Keytruda Combo in Triple-Negative Breast Cancer

More Data Support Trodelvy-Keytruda Combo in Triple-Negative Breast Cancer
ShareXFacebook

(MedPage Today) -- CHICAGO -- Sacituzumab govitecan (SG, Trodelvy) added to pembrolizumab (Keytruda) extended a surrogate measure of long-term clinical outcomes compared with chemotherapy plus pembrolizumab in patients with PD-L1-positive metastatic...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Protein Won't Solve Our Nutrition Problem
MedPage Today

Protein Won't Solve Our Nutrition Problem

(MedPage Today) -- Buffalo Wild Wings now offers an unusual new drink: "Espresso Proteini." Marketed for National Espresso Martini Day, the $12 drink includes 10 grams of Muscle Milk protein powder with a signature Buffalo dry rub rim. While the...

Read more →
Advertisement